Search results for "Anti-Allergic Agent"

showing 10 items of 22 documents

The Urticaria Activity Score-Validity, Reliability, and Responsiveness.

2018

Background Chronic spontaneous urticaria is characterized by fluctuating symptoms. Its activity is assessed with the urticaria activity score (UAS). Two versions of the urticaria activity score used for 7 consecutive days (UAS7) are available: (1) The guideline-recommended UAS7, with once-daily documentation, and (2) the UAS7TD, with twice-daily documentation. Objective To better characterize both UAS7 versions with regard to their validity, reliability, sensitivity to change, minimal important difference (MID), and smallest detectable change (SDC). Methods One hundred thirty adult patients with chronic spontaneous urticaria completed both UAS7 versions, the Patients Global Assessment (PatG…

AdultMalemedicine.medical_specialtyUrticariaIntraclass correlationOmalizumabOmalizumabSeverity of Illness IndexDisease activity030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeimmune system diseasesInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansskin and connective tissue diseasesReceiver operating characteristicbusiness.industryReproducibility of ResultsDermatology Life Quality IndexMiddle AgedStandard error030228 respiratory systemChronic DiseasePhysical therapyPatient-reported outcomeFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review

2020

This is a retrospective study of 18 children with chronic spontaneous urticaria (CSU), where standard therapies, including up-dosing of antihistamines and omalizumab, were unable to cure the disease and where alternative strategies with experimental and off-label medication had to be used. Being aware that our questionnaire is validated only for elder children or adults, we utilized the UAS7 to monitor disease control with the help of the parents. The UAS7 score decreased from a mean of 25 to an average of 13 after 8 weeks of therapy in 13 patients. Five patients had no significant reduction of UAS7 by week 8. In two of five patients, where periodic improvement was seen, omalizumab therapy …

AdultPediatricsmedicine.medical_specialtyUrticariaDermatologyOmalizumabOmalizumab030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseasesAnti-Allergic AgentsmedicineHumansChronic Urticariaskin and connective tissue diseasesChildAgedRetrospective Studies030203 arthritis & rheumatologybusiness.industryTreatment optionsRetrospective cohort studyDupilumabhumanitiesbody regionsTreatment OutcomeChronic Diseasebusinessmedicine.drug
researchProduct

Urticaria in children and adolescents: An updated review of the pathogenesis and management

2018

The present survey represents the latest data on diagnosis and management of childhood urticaria. It has been observed that urticaria occurs less often in children than adults, with symptoms rarely lasting for over 6 weeks. Triggers or aggravating factors can be found only in 21%-55% of cases. Finding autoantibodies in children does not impact a disease prognosis, unlike in adult patients, where the presence of autoantibodies is associated with a more prolonged run of the disease, a more severe prognosis and more intensive treatment methods. The incidence of food allergy equals to 8%-10% of cases. The incidence of Helicobacter Pylori infection in children is lower than that in adults and co…

Helicobacter pylori infectionPediatricsmedicine.medical_specialtyAdolescentUrticariaImmunologyOmalizumabDiseaseDiagnosis DifferentialPathogenesis03 medical and health sciences0302 clinical medicineFood allergyAnti-Allergic AgentsmedicineHumansImmunology and Allergy030212 general & internal medicineAggravating FactorChildbusiness.industryIncidence (epidemiology)Prognosismedicine.disease030228 respiratory systemChronic DiseasePractice Guidelines as TopicPediatrics Perinatology and Child HealthEtiologybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone …

2003

Immunotherapy is a recognized treatment for allergic respiratory diseases.

MaleParietaria; Androstadienes; Skin; Double-Blind Method; Combined Modality Therapy; Humans; Asthma; Child; Desensitization Immunologic; Anti-Allergic Agents; Plant Proteins; Pollen; Rhinitis Allergic Seasonal; Allergens; Treatment Outcome; Administration Inhalation; Adolescent; Administration Sublingual; Male; FemaleParietaria pollenAdolescentAdministration Sublingualsublingual immunotherapylate skin responsechildrenDouble-Blind Methodchildren; early skin response; fluticasone; late skin response; Parietaria pollen; sublingual immunotherapy; visual analog scoreAdministration InhalationChildSkinAndrostadieneAllergenearly skin responsefluticasonePlant ProteinRhinitis Allergic SeasonalCombined Modality TherapyAsthmaAnti-Allergic Agentvisual analog scoreParietariaTreatment OutcomeDesensitization ImmunologicPollenFemaleHuman
researchProduct

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

2016

Chronic spontaneous urticaria (CSU) is a skin disease that predominantly affects adults, especially women aged 20 to 40 years, and is characterized by the recurrent appearance of localized or widespread wheals, angioedema or both, without apparent external trigger. 1 , 2 Severe CSU has a detrimental effect on the quality of life and is a frequent cause of absenteeism from school and work. [3] The pathogenesis of CSU is not well understood, and it appears to have an autoimmune cause in approximately one-third of patients. [4] Guidelines for the management of CSU recommend the use of second-generation antihistamines, with the addition of leukotriene receptor antagonists, cyclosporine, or omal…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyUrticariabusiness.industryImmunologyMEDLINEOmalizumabOmalizumabDermatologyClinical PracticeAnti-Allergic Agents; Chronic Disease; Humans; Omalizumab; Urticaria; Immunology and Allergy; Pulmonary and Respiratory Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChronic disease030228 respiratory systemAnti-Allergic AgentsChronic DiseaseHumansMedicineImmunology and AllergybusinessAnti-Allergic Agentsmedicine.drug
researchProduct

Omalizumab and COVID-19 treatment: Could it help?

2020

Special Issue ArticlesCoronavirus disease 2019 (COVID-19)UrticariaPneumonia ViralMEDLINEOmalizumabDermatologyComorbidityOmalizumabBetacoronavirusCOVID‐19PandemicAnti-Allergic AgentsmedicineHumansPandemicsbiologybusiness.industryViral EpidemiologySARS-CoV-2COVID-19Special Issue ArticleGeneral Medicinemedicine.diseasebiology.organism_classificationVirologyComorbidityPneumoniaTherapybusinessCoronavirus InfectionsBetacoronavirusmedicine.drugDermatologic therapy
researchProduct

Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis tinctoria extracts and tryptanthrin.

2006

The effects of a supercritical CO2 (SFE) extract, a dichloromethane (DCM) extract from Isatis tinctoria leaf and the alkaloidal constituent tryptanthrin were studied in acute and subchronic experimental models of inflammation. The SFE and DCM extracts showed anti-inflammatory activity in the carrageenan-induced acute mouse paw oedema (ED50 values of 78 mg/kg and 165 mg/kg P. O., respectively) and in the acute tetradecanoylphorbol acetate (TPA)-induced mouse ear oedema in oral (62% and 32% oedema reduction at 100 and 125 mg/kg, respectively) and topical application (37% and 33% reduction of oedema at 0.5 mg/ear). In contrast, tryptanthrin showed no significant anti-inflammatory effect. The D…

Stereochemistrymedicine.drug_classAnti-Inflammatory AgentsPharmaceutical ScienceAdministration OralPharmacognosyPharmacologyAdministration CutaneousCarrageenanAnti-inflammatoryAnalytical Chemistrylaw.inventionchemistry.chemical_compoundMiceIn vivolawDrug DiscoveryAnti-Allergic AgentsmedicineHypersensitivityAnimalsEdemaIsatisED50Pharmacologybiologybusiness.industryPlant ExtractsOrganic ChemistryIsatisbiology.organism_classificationCarrageenanPlant LeavesComplementary and alternative medicinechemistryTetradecanoylphorbol AcetateQuinazolinesMolecular MedicineTetradecanoylphorbol AcetateFemalePhytotherapybusinessDrugs Chinese HerbalPhytotherapyPlanta medica
researchProduct

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab

2018

Urticariabusiness.industryImmunologyUrticària -- TractamentTotal igeOmalizumabOmalizumabImmunoglobulin E030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineText mining030228 respiratory systemAnti-Allergic AgentsChronic DiseaseImmunologyHumansImmunology and AllergyMedicineDrug Monitoringbusinessmedicine.drug
researchProduct

Modeling anti-allergic natural compounds by molecular topology.

2013

Molecular topology has been applied to the search of QSAR models able to identify the anti-allergic activity of a wide group of heterogeneous compounds. Through the linear discriminant analysis and artificial neural networks, correct classification percentages above 85% for both the training set and the test set have been obtained. After carrying out a virtual screening with a natural product library, about thirty compounds with theoretical anti-allergic activity have been selected. Among them, hesperidin, naringin, salinomycin, sorbitol, curcumol, myricitrin, diosmin and kinetin stand out. Some of these compounds have already been referenced as having anti-allergic activity.

Virtual screeningQuantitative structure–activity relationshipStereochemistryOrganic ChemistryDiosminDiscriminant AnalysisQuantitative Structure-Activity RelationshipGeneral MedicineComputational biologyLinear discriminant analysisModels BiologicalComputer Science Applicationschemistry.chemical_compoundHesperidinchemistryArtificial IntelligenceTest setDrug DiscoveryAnti-Allergic AgentsmedicineHumansNeural Networks ComputerMyricitrinNaringinmedicine.drugCombinatorial chemistryhigh throughput screening
researchProduct

The effect of allergen immunotherapy in the onset of new sensitizations: a meta-analysis.

2017

Background Although the preventive efficacy of allergen immunotherapy (AIT) in the onset of new allergen sensitizations has been asserted by many reviews, position papers, and consensus conferences, the evidence available is from only 3 studies. The objective of this work was a systematic review to evaluate the preventive efficacy of AIT in the onset of new allergen sensitizations. The end-point was the risk difference (RD) in the onset of new allergen sensitizations between patients treated with AIT and pharmacotherapy. Methods Computerized bibliographic searches of MEDLINE, EMBASE, and the Cochrane Library (until November 30th, 2016) were done. Random-effects and fixed-effects model meta-…

allergic rhinitisPyroglyphidaenew allergen sensitizationasthmameta-analysiDesensitization ImmunologicAnti-Allergic Agentsallergen immunotherapyHypersensitivityAnimalsHumansImmunizationAntigens DermatophagoidesChildRandomized Controlled Trials as TopicInternational forum of allergyrhinology
researchProduct